Home/Diakonos Oncology/Mike Wicks, MS
MW

Mike Wicks, MS

CEO and Board Member

Diakonos Oncology

Therapeutic Areas

Diakonos Oncology Pipeline

DrugIndicationPhase
DOC1021Glioblastoma (GBM)Phase 2